Discover great EU-funded Innovations
INNOVATOR
GENSPEED BIOTECH GMBH
SHARE:
DETAILS
Organisation type
Small or Medium Enterprise
Address
GEWERBEPARK 2
4261 RAINBACH IM MUHLKREIS
Austria
Contact
E-mail this innovator
Funding
Total H2020 EU funding 898k
GENSPEED Biotech GmbH is offering complete OEM solutions in rapid and multiplexed Point of Care Testing based on the proprietary multiplex Micro ELISA technology platform. The platform allows simultaneous quantification of up to 8 anayltes within 15 minutes in lab quality. The GENSPEED test portfolio based on our technology platform includes rapid immunoassays like COVID-19 IgG, TBE IgG xPOC and our newest Vitamin D xPOC Tests but also nucleic acid based tests like the PerioPOC Pro for rapid detection of key pathogens in periodontitis directly at the Dentist's office. GENSPEED Biotech distributes via distribution partners worldwide. https://www.genspeed-biotech.com
This innovator is on:
Economic sectors this organisation is active in:
  • HUMAN HEALTH AND SOCIAL WORK ACTIVITIES > Human health activities
  • MANUFACTURING > Manufacture of computer, electronic and optical products
  • PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES > Other professional, scientific and technical activities
 

Any video or documents linked to above have been placed on this page by GENSPEED BIOTECH GMBH and their presence on this page does not imply endorsement by the European Commission nor is the European Commission responsible for the content of these materials.

 
Partnership
This organisation is seeking partnerships of the following nature:
  • Research Partners
  • Investment
  • Strategic Business Partners
  • Distributors in new markets
  • Licensing opportunities
 
Innovations
This organisation has been identified as a Key Innovator for the following EU-funded innovation:
All innovations listed above are ranked by freshness of data, i.e. the innovations most recently analysed by Innovation Radar appear at the top